2-Amino-6-methoxypurine Arabinoside: An Agent for T-Cell Malignancies

Cancer Research

Volumn 55, Issue 15, 1995, Pages 3352-3356

  Lambe, Catherine U ^a   Averett, Devron R ^a   Paff, Melanie T ^a   Reardon, John E ^a   Wilson, Joan G ^a   Krenitsky, Thomas A ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE KINASE; ANTINEOPLASTIC AGENT; COFORMYCIN; DEOXYCYTIDINE KINASE; DNA POLYMERASE; GUANINE ARABINOSIDE; MITOCHONDRIAL DNA; NELARABINE; PENTOSTATIN; PHOSPHORYLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; DOSE RESPONSE; DRUG DNA INTERACTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SOLUBILITY; DRUG SPECIFICITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MONKEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T CELL LEUKEMIA;

ANIMAL; ANTINEOPLASTIC AGENTS; ARABINONUCLEOSIDES; ARABINONUCLEOTIDES; DNA-DIRECTED DNA POLYMERASE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GUANOSINE TRIPHOSPHATE; HUMAN; LEUKEMIA, B-CELL; LEUKEMIA, T-CELL; MACACA FASCICULARIS; MICE; MICE, NUDE; PRODRUGS; TUMOR CELLS, CULTURED;

EID: 0029127419     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Champlin, R., and Gale, R. P. Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood, 73: 2051–2066, 1989.
2. Cohen, S. S. The lethality of aranucleosides. Med. Biol., 54: 299–326, 1976.
3. Stone, R. M., Spriggs, D. R., Dhawan, R. K., Arthur, K. A., Mayer, R. J., and Kufe, D. W. A Phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia. Leukemia (Baltimore), 4: 843–847, 1990.
4. Giblett, E. R., Anderson, J. E., Cohen, F., Pollara, B., and Meuwissen, H. J. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet, 2: 1067–1069, 1972.
5. Giblett, E. R., Ammann, A. J., Wara, D. W., Sandman, R., and Diamond, L. K. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet, I: 1010–1013, 1975.
6. Kredich, N. M., and Hershfield, M. S. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside Phosphorylase deficiency. In: J. D. Jeffers and G. Gavert (eds.), The Metabolic Basis of Inherited Disease, pp. 1045–1075. New York: McGraw-Hill, 1989.
7. Mitchell, B. S., Mejias, E., Daddona, P. E., and Kelley, W. N. Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells. Proc. Natl. Acad. Sci. USA, 75: 5011–5014, 1978.
8. Scharenberg, J. G., Spaapen, L. J., Rijkers, G. T., Wadman, S. K., Staal, G. E., and Zegers, B. J. Mechanisms of deoxyguanosine toxicity for human T and B lymphocytes. Adv. Exp. Med. Biol., 195: 191–199, 1986.
9. Fridland, A., and Verhoef, V. Metabolism and selectivity of arabinonucleoside in human lymphoid cells. Proc. Soc. Exp. Biol. Med., 179: 456–462, 1985.
10. Verhoef, V., and Fridland, A. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. Cancer Res., 45: 3646–3650, 1985.
11. Cohen, A., Lee, J. W. W., and Gelfand, E. W. Selective toxicity of deoxyguanosine and arabinosyl guanine for T-leukemic cells. Blood, 61: 660–666, 1983.
12. Ullman, B., and Martin, D. W., Jr. Specific cytotoxicity of arabinosyl-guanine toward cultured T lymphoblasts. J. Clin. Invest., 74: 951–955, 1984.
13. Shewach, D. S., Daddona, P. E., Ashcraft, E., and Mitchell, B. S. Metabolism and selective cytotoxicity of 9-β-D-arabinofuranosylguanine in human lymphoblasts. Cancer Res., 45: 1008–1014, 1985.
14. Shewach, D. S., and Mitchell, B. S. Differential metabolism of 9-β-D-arabinofuranosylguanine in human leukemic cells. Cancer Res., 49: 6498–6502, 1989.
15. Krenitsky, T. A., Turtle, J. V., Koszalka, G. W., Chen, I. S., Beacham, L. M., Rideout, J. L., and Elion, G. B. Deoxycytidine kinase from calf thymus: substrate and inhibitor specificity. J. Biol. Chem., 251: 4055–4061, 1976.
16. Lewis, R. A., and Link, L. Phosphorylation of arabinosyl guanine by a mitochondrial enzyme of bovine liver. Biochem. Pharmacol., 38: 2001–2006, 1989.
17. Hebert, M. E., Greenberg, M. L., Chaffee, S., Gravatt, L., Hershfield, M. S., Elion, G. B., and Kurtzberg, J. Pharmacologie purging of malignant T cells from human bone marrow using 9-β-D-arabinofuranosylguanine. Transplantation (Baltimore), 52: 634–640, 1991.
18. Gravatt, L. C., Chaffee, S., Hebert, M. E., Halperin, E. C., Friedman, H. S., and Kurtzberg, J. Efficacy and toxicity of 9-β-D-arabinofuranosylguanine (ara-G) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model. Leukemia (Baltimore), 7: 1261–1267, 1993.
19. Krenitsky, T. A., Koszalka, G. W., Turtle, J. V., Rideout, J. L., and Elion, G. B. An enzymic synthesis of purine-D-arabinonucleosides. Carbohydrate Res., 97: 139–146, 1981.
20. Averett, D. R., Koszalka, G. W., Fyfe, J. A., Roberts, G. B., Purifoy, D. J. M., and Krenitsky, T. A. 6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus. Antimicrob. Agents Chemother., 35: 851–857, 1991.
21. Schaffer, H. J., and Schwender, C. F. Enzyme inhibitors. 26. Bridging hydrophobic and hydrophilic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)-adenines. J. Med. Chem., 17: 6–8, 1974.
22. Martin, J. L., Brown, C. E., Matthews-Davis, N., and Reardon, J. E. Effects of antiviral nucleoside analogs on human polymerases and mitochondrial DNA synthesis. Antimicrob. Agents Chemother., 38: 2743–2744, 1995.
23. Reardon, J. E. Human immunodeficiency virus reverse transcriptase: a kinetic analysis of RNA-dependent and DNA-dependent DNA polymerization. J. Biol. Chem., 268: 8743–8751, 1993.
24. Aposhian, H. V., and Kornberg, A. Enzymatic synthesis of deoxyribonucleic acid. IX. The polymerase formed after T2 bacteriophage infection of Escherichia coli: a new enzyme. J. Biol. Chem., 237: 519–525, 1962.
25. Miller, R. L., Adamczyk, D. L., Miller, W. M., Koszalka, G. W., Rideout, J. L., Beacham, L. M., Chao, E. Y., Haggerty, J. J., Krenitsky, T. A., and Elion, G. B. Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity. J. Biol. Chem., 254: 2346–2352, 1979.
26. Tuttle, J. V., and Krenitsky, T. A. Effects of acyclovir and its metabolites on purine nucleoside Phosphorylase. J. Biol. Chem., 259: 4065–4069, 1984.
27. Spector, T., Jones, T. E., and Beacham, L. M., III. Conversion of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine to acyclovir as catalyzed by adenosine deaminase. Biochem. Pharmacol., 32: 2505–2509, 1983.
28. Reardon, J. E. Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation. Biochemistry, 31:4473–4479,1992.
29. Averett, D. R. Anti-HIV compound assessment by two novel high-capacity assays. J. Virol. Methods, 23: 263–276, 1989.
30. Prus, K. L., Averett, D. R., and Zimmerman, T. P. Transport and metabolism of 9-β-D-arabinofuranosylguanine in a human T-lymphoblastoid cell line: nitrobenzyl-thioinosine-sensitive and -insensitive influx. Cancer Res., 50: 1817–1821, 1990.
31. Foley, G. E., Lazarus, H., Farber, S., Uzman, B. G., Boone, B. A., and McCarthy, R. F. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer (Phila.), 18: 522–529, 1965.
32. Paff, M. T., Averett, D. R., Prus, K. L., Miller, W. H., and Nelson, D. J. Intracellular metabolism of (-)- and (+)-cis-5-fluoro-l-[2-(hydroxymethyl)-l,3-oxathiolan-5-yljcytosine in HepG2 derivative 2.2.15 (subclone P5A) cells. Antimicrob. Agents Chemother., 38: 1230–1238, 1994.
33. Moorman, A. R., Chamberlain, S. D., Jones, L. A., de Miranda, P., Reynolds, D. J., Peoples, M. E., and Krenitsky, T. A. 5’-Ester prodrugs of the varicella-zoster antiviral agent, 6-methoxypurine arabinoside. Antiviral Chem. Chemother., 3: 141–146,1992.
34. Henderson, J. F., Brox, L., Zombor, G., Hunting, D., and Lomax, C. A. Specificity of adenosine deaminase inhibitors. Biochem. Pharmacol., 26: 1967–1972, 1977.
35. Kamel-Reid, S., and Dick, J. E. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science (Washington DC), 242: 1706–1709, 1988.
36. Krenitsky, T. A. Tissue distribution of purine ribosyl- and phospho-ribosyltrans-ferases in the Rhesus monkey. Biochim. Biophys. Acta, 179: 506–509, 1969.
37. Ono, K., Ohashi, A., Yamamoto, A., Matsukage, A., Takahasi, T., Saneyoshi, M., and Ueda, T. Inhibitory effects of 9-β-D-arabinofuranosylguanine 5’-triphosphate and 9-β-D-arabinofuranosyladenine 5’-triphosphate on DNA polymerases from murine cells and oncornavirus. Cancer Res., 39: 4673–4680, 1979.
38. Ohno, Y., Spriggs, D., Matsukage, A., Ohno, T., and Kufe, D. Sequence-specific inhibition of DNA strand elongation by incorporation of 9-β-D-arabinofuranosyladenine. Cancer Res., 49: 2077–2081, 1989.
39. Huang, P., Chubb, S., and Plunkett, W. Termination of DNA synthesis by 9-β-r>arabinofuranosyl-2-fluoroadenine. J. Biol. Chem., 265: 16617–16625, 1990.
40. Perrino, F. W., and Mekosh, H. L. Incorporation of cytosine arabinoside monophosphate into DNA at internucleotide linkages by human DNA polymerase α. J. Biol. Chem., 267: 23043–23051, 1992.
41. Mikita, T., and Beardsley, G. P. Functional consequences of the arabinosylcytosine structural lesion in DNA. Biochemistry, 27: 4698–4705, 1988.
42. Kuchta, R. D., Ilsley, D., Kravig, K. D., Schubert, S., and Harris, B. Inhibition of DNA primase and polymerase α by arabinofuranosylnucleoside triphosphates and related compounds. Biochemistry, 31: 4720–4728, 1992.
43. Catapano, C. V., Perrino, F. W., and Fernandes, D. J. Primer RNA chain termination induced by 9-β-D-arabinofuranosyl-2-fluoroadenine 5’-triphosphate. J. Biol. Chem., 268: 7179–7185, 1993.
44. Arnaudo, E., Moraes, C. T., Dalakas, M., DiMauro, S., Shanske, S., and Schon, E. A. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet, 337: 508–510, 1991.
45. Chen, C.-H., and Cheng, Y-C. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2’,3’-dideoxycytidine. J. Biol. Chem., 264: 11934–11937, 1989.